Theravance Biopharma, Inc.
TBPH Real Time Price USDRecent trades of TBPH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TBPH's directors and management
Government lobbying spending instances
-
$40,000 Nov 02, 2021 Issue: Health Issues
-
$40,000 Jul 20, 2021 Issue: Health Issues
-
$30,000 Jul 19, 2021 Issue: Health Issues
-
$30,000 Apr 14, 2021 Issue: Health Issues
-
$20,000 Jan 21, 2021 Issue: Health Issues
-
$20,000 Oct 07, 2020 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Processes for preparing a pan-jak inhibitor and related intermediate compounds Aug. 29, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of TBPH in WallStreetBets Daily Discussion
Recent insights relating to TBPH
Recent picks made for TBPH stock on CNBC
ETFs with the largest estimated holdings in TBPH
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TBPH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.